About Acadia
Driven by urgency and the reality that too many patients have few or no treatment options, we are committed to advancing where others hesitate.
Bringing Innovative Treatments to Patients
Inspired by the patients and families who count on us, Acadians across North America, Europe, and beyond dedicate their work to advancing therapies in underserved neurological disorders and rare diseases. Their collective expertise drives innovations that bring meaningful moments and brighter futures to patients and loved ones around the world.
Life at Acadia
We collaborate with patients, caregivers, and healthcare providers to guide innovation at every step. Their lived experiences shape our science and ensure our therapies address the most urgent needs in underserved neurological disorders and rare diseases.
Acadia Leadership
The foundation of any organization is its people—our expertise in neurological disorders and rare diseases is built on leaders who have dedicated their careers to bringing innovations to those most in need.
Diversity, Equity, Inclusion & Belonging (DEIB)
Each day, we work to create an environment where our employees are inspired by our commitment to one another, the people we serve, and the power of science to change lives.
Corporate Responsibility
Helping people living with disease begins with an ethos anchored in ethics and sustainability.
Our History
Our history is rooted in groundbreaking science. From developing the first and only treatment for hallucinations and delusions in Parkinson’s disease psychosis to commercializing the first therapy for Rett syndrome, Acadia has consistently advanced care where it is most needed. Today, with a proven commercial portfolio and a diverse pipeline, we are poised to lead the next era of therapeutic innovation in neurological disorders and rare diseases.
